information

Whoever comes in this website may find a hint

Phage therapy is influenced by:

Phage therapy is influenced by:

Country :
the epidemiological situation is different from country to country in terms of circulating bacteria and bacteriophages. Example: a lytic phages from Italy may be no active on the same bacteria (genus and species) isolated from another country and vice versa.
Chronolability
Mutation rate
Phenotypical delay
Phage cocktail
My point of view

From Wikipedia


If the target host* of a phage therapy treatment is not
an animal the term "
biocontrol" (as in phage-mediated biocontrol of bacteria) is usually employed, rather than "phage therapy".

"In silico"

From:"Genomics,Proteomics and Clinical Bacteriology", N.Woodford and Alan P.Johnson

Phrase that emphasizes the fact that many molecular biologists spend increasing amounts of their time in front of a computer screen, generating hypotheses that can subsequently be tested and (hopefully) confirmed in the laboratory.

Showing posts with label Mycobacterium ulcerans Agy99. Show all posts
Showing posts with label Mycobacterium ulcerans Agy99. Show all posts

Wednesday, 3 September 2014

Mycobacterium ulcerans strain Agy99 and its 174-kb pMUM001 plasmid


I quote the passages from:

Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans

"...MU contains a 174-kb plasmid, pMUM001, bearing a cluster of genes encoding giant polyketide synthases (PKSs), and polyketide-modifying enzymes, and demonstrate that these are necessary and sufficient for mycolactone synthesis."

"...reflects the acquisition of pMUM001 by horizontal transfer."

"...The 12-membered core of mycolactone is produced by two giant, modular PKSs,
MLSA1 (1.8 MDa) and MLSA2 (0.26 MDa), whereas its side chain is synthesized by MLSB (1.2 MDa), a third modular PKS highly related to MLSA1."

"...There is an extreme level of sequence identity within the different domains of the MLS cluster (>97% amino acid identity), so much so that the 16 ketosynthase domains seem functionally identical."

"..confirming the existence in MU of a circular plasmid, designated pMUM001, comprising 174,155 bp, with a GC content of 62.8% and carrying 81 protein-coding DNA sequences."

"..Replication seems to be initiated by the predicted product of repA, which shares
68.3% amino acid identity with RepA from the cryptic Mycobacterium fortuitum plasmid, pJAZ38 (10)"

"..Two different direct repeat regions were identified 500–1,000 bp upstream of repA, suggesting possible replication origins (ori). GC-skew plots [(G - C) (G+ C)], which highlight compositional biases between leading and lagging DNA strands, displayed a random pattern and did not help pinpoint a possible ori (Fig. 2)."

"..Approximately 2 kb downstream of repA is parA, a gene encoding a chromosome partitioning protein, required for plasmid segregation on cell division. In this region, there is also a potential regulatory gene cluster composed of a serine threonine protein kinase (mup008), a gene encoding a protein of unknown function(mup018) but containing a phosphopeptide recognition domain,a domain found in many regulatory proteins (11), and a WhiB like transcriptional regulator (mup021)."

"...The plasmid is rich in insertion sequences (IS), with 26 examples, including
4 copies of IS2404 and 8 copies of IS2606 (13)."

Circular presentation of pMUM001:





 

My contribution for pMUM001 plasmid seen from a new perspective by Dot-plot analysis :


by virtual 2G gel:

PKS,polyketide synthase
KS, ketosynthase
TE, thioesterase

by UGENE

Tuesday, 29 July 2014

Mycobacterium ulcerans prophages


Most probably the idea to utilize Phage Therapy in human Buruli disease is impracticable at moment.

In the Net there is not any information about this but only one scientific work with mouse model.

In spite of everything I think it is useful to try all possibilities for exploring new forms of drugs in Buruli disease and among these also Phage therapy.

I quote the passages from :

Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer


".....771 pseudogenes, two bacteriophages, and multiple DNA deletions and rearrangements."

"The two prophages named phiMU01 (18 kb, 18 CDS) and phiMU02 (24 kb, 17 CDS) resemble other mycobacteriophages in overall structure, integrating near tRNA genes and containing CDS associated with replication functions. However, phiMU02 may be non-functional, as several of its genes have been inactivated by multiple IS2606 insertions."








"...and acquisition of foreign genes, often via plasmids or bacteriophage, that confer a fitness advantage in the new environment."

I want to check the passages quoted above because they are not described in details:

1° passage:

"The two prophages named phiMU01 (18 kb, 18 CDS) and phiMU02 (24 kb, 17 CDS) resemble other mycobacteriophages in overall structure, integrating near tRNA genes and containing CDS associated with replication functions."

In the beginning if these prophages were mycobacterium phages probably they have still some common features with other Mycobacterium phage genomes like D29,L5, BXZ2 and TM4.

2° passage:

"...phiMU02 may be non-functional, as several of its genes have been inactivated by multiple IS2606 insertions."


Checking by Gepard software

 phiMU01 versus phiMU01:
 
 


 phiMU02 versus phiMU02:


 
 explanation:



 By Mauve software and M-GCAT sofware the genomes are compared:

 phiMU01 versus phiMU02:










  alignment by JAligner



Now to shoot off :

a-
For avoiding misunderstandings I have written the words by WIKIPEDIA:

Prophage:
A prophage is a phage genome inserted as part of the linear structure of the DNA chromosome of a bacterium. A temperate phage integrated into the host chromosome or existing as an extrachromosomal plasmid. This is a latent form of a bacteriophage in which the viral genes are incorporated into the bacterial chromosomes without causing disruption of the bacterial cell.
Upon detection of host cell damage, the prophage is excised from the bacterial chromosome in a process called prophage induction. After induction, viral replication begins via the lytic cycle. Prophages are important agents of horizontal gene transfer, and are considered to be part of the mobilome.

Bacteriophage

b-phiMU01 and phiMU02 sequences are extracted from Mycobacterium ulcerans genome by Artemis software :

>misc_feature misc_feature Prophage phiMU01 523696:542119 forward
CCTTGCCGATAGACGGTACCGGCGCGCCCTGACGGGA
CGCGAACGATCAAGAAGCTACCCGCGCCGGTGTCGCT
GGACGGCACTCTAATAACGTCGCGGCTCGCTGGCGTT
GGAATTCAG..........AATC
>misc_feature misc_feature Prophage phiMU02 3582899:3606951 reverse
GTCAAGTGGTCGCAGGTTCAAATCCTGTCAGCCCGACCA
GAACGTTCTTACTCAAACCAGTGACCGAAAAGACACCGG
CCAAGGTGAGCGACTCCGTTCCGGTGGATCTAGGAGCC
CCTG......ACAT
c- each prophage genome is examined and compared with D29, L5,TM4 and BXZ2 genomes by Gepard software:


phiMU01 versus D29 phage :
 

 phiMU01, phiMU02 versus D29 phage:




The LCB weight sets the minimum number of matching nucleotides identified in a collinear region for that region to be considered true homology versus random similarity.

 phiMU01, phiMU02 versus Bxz2 phage:





 phiMU01, phiMU02 versus L5 phage:




 phiMU01, phiMU02 versus TM4 phage:



 all phages above:





Conclusions :

phiMU01 versus D29 phage



 all phages above:





This analysis reinforces my conviction about the presence in the soil , fresch water or in other sources of specific phages for Mycobacterium ulcerans. I am sure "nothing seek, nothing find".

phiMmar01


Why?

Mycobacterium ulcerans prophages



By Artemis :



By Mauve:


By Gepard :


phiMmar01/phiMmar01




phiMU01/phiMmar01




phiMU02/phiMmar01



MU and Mmar Prophages






Integrase Comparison


Going in search of phages for Mycobacterium ulcerans


This is my opinion about the question.

In practice at the moment I do not have the possibility to search phages for Mycobacterium ulcerans but, if I do not have real phages, however, I can study all potential phages (prophages) inside Mycobacterium marinum and Mycobacterium ulcerans genome.


1-If I find some correlations among "prophages" of these Mycobacteria I have further evidence that M. ulcerans is originated from M.marinum.

2-If I find some correlations between "prophages" of these Mycobacteria I have further evidence that specific phages for M. ulcerans and M.marinum could exist.



I quote the passage from:

Insights from the complete genome sequence of
Mycobacterium marinum on the evolution of Mycobacterium tuberculosis

"...and 10 putative prophages, named phiMmar01–10 (Supplemental Table 2)."




I will study these potential "prophages" one by one.

Sunday, 20 July 2014

KEGG: Mycobacterium ulcerans

KEGG Mycobacterium ulcerans

Genome information

T numberT00435
Org codemul
AliasesMYCUA, 362242
Full nameMycobacterium ulcerans
DefinitionMycobacterium ulcerans Agy99
Annotationmanual
TaxonomyTAX: 362242
    LineageBacteria; Actinobacteria; Actinobacteridae;                                                                                  Actinomycetales;Corynebacterineae;                                                                                 Mycobacteriaceae; Mycobacterium
Data sourceRefSeq (Assembly:GCA_000013925.1)
Original DBPasteur
KeywordsHuman pathogen
DiseaseH00285 Blau syndrome
H01042 Buruli ulcer
CommentIsolated from an ulcerative lesion on the right elbow                                                                    of a female patient from the Ga district of Ghana in 1999
ChromosomeCircular
    SequenceRS: NC_008611
    Length5631606
PlasmidpMUM001; Circular
    SequenceRS: NC_005916
    Length174155
StatisticsNumber of nucleotides: 5805761
Number of protein genes: 4241
Number of RNA genes: 50
ReferencePMID: 17210928
    AuthorsStinear TP, et al.
    TitleReductive evolution and niche adaptation inferred from                                                               the genome of Mycobacterium ulcerans, the causative                                                         agent of Buruli ulcer.
    JournalGenome Res 17:192-200 (2007)





Summary of Mycobacterium ulcerans, Strain Agy99

From: BioCyc Database Collection



RepliconTotal GenesProtein GenesRNA GenesPseudogenesSize (bp)

Chromosome 149814931507715,631,606
Plasmid 1818100174,155

Total:50625012507715,805,761


Pathways:193
Enzymatic Reactions:1209
Transport Reactions:53

Polypeptides:4241
Protein Complexes:11
Enzymes:841
Transporters:67

Compounds:806

Transcription Units:3542
tRNAs:51

Saturday, 19 July 2014

Mycobacterium ulcerans Agy99


        Browse Genome         BLAST Genome        
About Genome

Overview


Proposal Name Mycobacterium ulcerans Agy99
Organism Name Mycobacterium ulcerans Agy99
Taxon ID 642555140
NCBI Taxon ID 362242
GOLD ID in IMG Database Project ID: Gc00469  
External Links ; NCBI/RefSeq:NC_005916; NCBI/RefSeq:NC_008611; PUBMED:14736915; PUBMED:17210928 
Lineage Bacteria; Actinobacteria; Actinobacteria; Actinomycetales; Mycobacteriaceae; Mycobacterium; ulcerans
Sequencing Status Finished
IMG Release IMG/W 2.7
Comment  
Release Date 2008-12-01
Add Date 2008-09-20
Modified Date 2011-08-16
Distance Matrix Calc. Date 2014-07-02
High Quality Yes
Is Public Yes
Project Information  
Cultured Yes
Culture Type Isolate
Geographic Location ulcerative lesion on the right elbow of a female patient from the Ga district of Ghana in 1999
GOLD ID Gc00469
Isolation Country Ghana
Isolation Year July, 1999
NCBI Project ID 16230
Publication Journal Genome Res. (17, 192-200)
GOLD Sequencing Status Complete
Project Sequencing Method Sanger
Sequencing Center Institut Pasteur
Metadata  
Assembly Method Phrap, Gap4
Biotic Relationships Free living
Cell Shape Rod-shaped
Ecosystem Host-associated
Ecosystem Category Human
Ecosystem Type Unclassified
Ecosystem Subtype Unclassified
Gram Staining Gram+
Host Name Homo sapiens
Host Gender Female
Host Health Patient
Isolation ulcerative lesion on the right elbow of a female patient from the Ga district of Ghana in 1999
Library Method 2-3Kb, 3-5Kb, 5-10Kb
Motility Nonmotile
Oxygen Requirement Aerobe
Specific Ecosystem Unclassified
Sporulation Nonsporulating
Temperature Range Mesophile
Temperature Optimum 32
Sample Body Site Skin
Relevance Medical, Human Pathogen
Phenotype Pathogen, Antibiotic resistant
Habitat Host, Fresh water
Diseases Buruli ulcer
Cell Arrangement Singles
Energy Source Chemoorganotroph
Phenotypes/Metabolism from Pathway Assertion  
Metabolism Auxotroph (L-lysine auxotroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-alanine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-aspartate prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-glutamate prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Auxotroph (L-phenylalanine auxotroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Auxotroph (L-tyrosine auxotroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Auxotroph (L-tryptophan auxotroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Auxotroph (L-histidine auxotroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Auxotroph (Glycine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-arginine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-asparagine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-cysteine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-glutamine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-isoleucine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Auxotroph (L-leucine auxotroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-proline prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-serine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-threonine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-valine prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism (Non-selenocysteine synthesizer) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (Biotin prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (Coenzyme A prototroph) (IMG_PIPELINE; 2012-10-10)
Metabolism (Glucose utilizing) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-methionine synthesis with homocysteine as intermediate) (IMG_PIPELINE; 2012-10-10)
Metabolism Prototrophic (L-methionine synthesis with methanethiol) (IMG_PIPELINE; 2012-10-10)

Genome Statistics



Hint To view rows that are zero, go to MyIMG preferences
and set "Hide Zeroes in Genome Statistics" to "No".



Number % of Total
DNA, total number of bases 5805761 100.00%
        DNA coding number of bases 4236262 72.97%
        DNA G+C number of bases 3796479 65.39% 1
                       
DNA scaffolds 2 100.00%
        Plasmid Count 1  
                       
Genes total number 4306 100.00%
        Protein coding genes 4241 98.49%
        RNA genes 65 1.51%
                rRNA genes 3 0.07%
                        5S rRNA 1 0.02%
                        16S rRNA 1 0.02%
                        23S rRNA 1 0.02%
                tRNA genes 45 1.05%
                Other RNA genes 17 0.39%
        Protein coding genes with function prediction 2792 64.84%
                without function prediction 1449 33.65%
        Protein coding genes connected to SwissProt Protein Product 340 7.90%
                not connected to SwissProt Protein Product 3901 90.59%
        Protein coding genes with enzymes 1007 23.39%
        w/o enzymes but with candidate KO based enzymes 10 0.23%
        Protein coding genes connected to Transporter Classification 293 6.80%
        Protein coding genes connected to KEGG pathways3 1053 24.45%
                not connected to KEGG pathways 3188 74.04%
        Protein coding genes connected to KEGG Orthology (KO) 1735 40.29%
                not connected to KEGG Orthology (KO) 2506 58.20%
        Protein coding genes connected to MetaCyc pathways 988 22.94%
                not connected to MetaCyc pathways 3253 75.55%
        Protein coding genes with COGs3 2592 60.20%
                with KOGs3 1546 35.90%
                with Pfam3 3619 84.05%
                with TIGRfam3 1074 24.94%
                with InterPro 3572 82.95%
                with IMG Terms 870 20.20%
                with IMG Pathways 336 7.80%
                with IMG Parts List 322 7.48%
                in paralog clusters 2561 59.48%
                in Chromosomal Cassette 4306 100.00%
        Chromosomal Cassettes 673 -
        Biosynthetic Clusters 69 -
                Genes in Biosynthetic Clusters 980 22.76%
        Fused Protein coding genes 352 8.17%
        Protein coding genes coding signal peptides 298 6.92%
        Protein coding genes coding transmembrane proteins 839 19.48%
COG clusters 1326 51.16%
KOG clusters 725 27.97%
Pfam clusters 1778 49.13%
TIGRfam clusters 881 82.03%
Notes:
1 - GC percentage shown as count of G's and C's divided by the total number of bases.
      The total number of bases is not necessarily synonymous with a total number of G's, C's, A's, and T's.
2 - Pseudogenes may also be counted as protein coding or RNA genes, so is not additive under total gene count. 3 - Graphical view available.

Browse Genome




Phylogenetic Distribution of Genes



Putative Horizontally Transferred Genes




Compare Gene Annotations


Gene annotation values are precomputed and stored in a tab delimited file
also viewable in Excel.

Scaffold Consistency Check


Export Gene Information


Gene information is precomputed and stored in a tab delimited file
also viewable in Excel.

Export Genome Data


Scaffold Search


Scaffold search allows for seaching for all scaffolds within an organism or microbiome.
Please enter a search term or matching substring for scaffold name or read ID.


or enter low and high range for
-